. Eli Lilly and Company (NYSE: LLY) announced today that the U. New data show therapy reduced risk of hospitalizations and death by 00 percent - Second positive Phase 0 trial readout for bamlanivimab and etesevimab. Trial participants taking the highest dose of tirzepatide (00 mg) achieved an A0C reduction of 0. NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) will participate in the first quarter of 0000 increased 00 percent, driven by volume growth of 00 percent. March 00, 0000 00:00 PM Eastern Daylight Time NEW YORK and INDIANAPOLIS-( BUSINESS WIRE )-Pfizer Inc. Rau succeeds Aarti Shah, whose planned retirement was announced in 0000. Trial participants taking the highest dose of tirzepatide (00 mg) achieved an A0C reduction of 